Rossari Biotech are one of the leading specially chemicals
manufacturing companies in India providing customized solutions to specific industrial
and productin.
As Rossari Biotech gears up to
launch its initial public offering (IPO) on Monday, unlisted shares of the
company are demanding up to 30-35 per cent premium over the IPO price in grey
market or unofficial market for trading in unlisted shares.
The company has fixed the
price band of the issue at Rs 423-425. Grey market traders are expecting the
issue to list at a hefty premium.
In the Pre-IPO market, premium
on the shares shot up to Rs 140 on Wednesday, July 8, from Rs 20 on Monday,
July 6. Traders are expecting the premium to rise further till issue closes for
subscription.
Narottam Dharawat of Dharawat
Securities, a Mumbai based firm that deals in unlisted shares, said the premium
is rising as the IPO is inching closer. “It is likely to move northward in the
next few days,” he said.
It is the first IPO after the Covid-19 outbreak sent the equity market haywire and stalled companies’ plans to raise fresh capital. Rossari had held up the issue in March amid the pandemic scare.
Sandip Ginodia , CEO
ALTIUS INVESTECH PVT LTD
We deal in over 60 unlisted companies with 15 years of experience .
Email : ginodiasandip1@gmail.com
Comments
Post a Comment
Please leave your name and email id along with the comment .
Get the updates from this blog direct to your inbox . Fill in your email id on the home page.